BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 25677313)

  • 21. CD8+ T cells mediate the athero-protective effect of immunization with an ApoB-100 peptide.
    Chyu KY; Zhao X; Dimayuga PC; Zhou J; Li X; Yano J; Lio WM; Chan LF; Kirzner J; Trinidad P; Cercek B; Shah PK
    PLoS One; 2012; 7(2):e30780. PubMed ID: 22347402
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Natural regulatory T cells limit angiotensin II-induced aneurysm formation and rupture in mice.
    Ait-Oufella H; Wang Y; Herbin O; Bourcier S; Potteaux S; Joffre J; Loyer X; Ponnuswamy P; Esposito B; Dalloz M; Laurans L; Tedgui A; Mallat Z
    Arterioscler Thromb Vasc Biol; 2013 Oct; 33(10):2374-9. PubMed ID: 23908246
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dose-Dependent Bidirectional Effect of Angiotensin IV on Abdominal Aortic Aneurysm via Variable Angiotensin Receptor Stimulation.
    Kong J; Zhang K; Meng X; Zhang Y; Zhang C
    Hypertension; 2015 Sep; 66(3):617-26. PubMed ID: 26238445
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Urokinase-type plasminogen activator plays a critical role in angiotensin II-induced abdominal aortic aneurysm.
    Deng GG; Martin-McNulty B; Sukovich DA; Freay A; Halks-Miller M; Thinnes T; Loskutoff DJ; Carmeliet P; Dole WP; Wang YX
    Circ Res; 2003 Mar; 92(5):510-7. PubMed ID: 12600880
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevention of Progression of Aortic Aneurysm by Peptide Vaccine Against Ang II (Angiotensin II) in a Rat Model.
    Kurashiki T; Miyake T; Nakagami H; Nishimura M; Morishita R
    Hypertension; 2020 Dec; 76(6):1879-1888. PubMed ID: 33040618
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cathepsin K gene disruption does not affect murine aneurysm formation.
    Bai L; Beckers L; Wijnands E; Lutgens SP; Herías MV; Saftig P; Daemen MJ; Cleutjens K; Lutgens E; Biessen EA; Heeneman S
    Atherosclerosis; 2010 Mar; 209(1):96-103. PubMed ID: 19775691
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Early increased MT1-MMP expression and late MMP-2 and MMP-9 activity during Angiotensin II induced aneurysm formation.
    Eagleton MJ; Ballard N; Lynch E; Srivastava SD; Upchurch GR; Stanley JC
    J Surg Res; 2006 Oct; 135(2):345-51. PubMed ID: 16716358
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A CD31-derived peptide prevents angiotensin II-induced atherosclerosis progression and aneurysm formation.
    Fornasa G; Clement M; Groyer E; Gaston AT; Khallou-Laschet J; Morvan M; Guedj K; Kaveri SV; Tedgui A; Michel JB; Nicoletti A; Caligiuri G
    Cardiovasc Res; 2012 Apr; 94(1):30-7. PubMed ID: 22293851
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunization using ApoB-100 peptide-linked nanoparticles reduces atherosclerosis.
    Chyu KY; Zhao X; Zhou J; Dimayuga PC; Lio NW; Cercek B; Trac NT; Chung EJ; Shah PK
    JCI Insight; 2022 Jun; 7(11):. PubMed ID: 35536648
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 17 Beta-estradiol attenuates development of angiotensin II-induced aortic abdominal aneurysm in apolipoprotein E-deficient mice.
    Martin-McNulty B; Tham DM; da Cunha V; Ho JJ; Wilson DW; Rutledge JC; Deng GG; Vergona R; Sullivan ME; Wang YX
    Arterioscler Thromb Vasc Biol; 2003 Sep; 23(9):1627-32. PubMed ID: 12855485
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inadequate reinforcement of transmedial disruptions at branch points subtends aortic aneurysm formation in apolipoprotein-E-deficient mice.
    Gavish L; Beeri R; Gilon D; Rubinstein C; Berlatzky Y; Gavish LY; Bulut A; Harlev M; Reissman P; Gertz SD
    Cardiovasc Pathol; 2014; 23(3):152-9. PubMed ID: 24480303
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Angiopoietin-2 attenuates angiotensin II-induced aortic aneurysm and atherosclerosis in apolipoprotein E-deficient mice.
    Yu H; Moran CS; Trollope AF; Woodward L; Kinobe R; Rush CM; Golledge J
    Sci Rep; 2016 Oct; 6():35190. PubMed ID: 27767064
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Angiotensin II is associated with activation of NF-kappaB-mediated genes and downregulation of PPARs.
    Tham DM; Martin-McNulty B; Wang YX; Wilson DW; Vergona R; Sullivan ME; Dole W; Rutledge JC
    Physiol Genomics; 2002 Oct; 11(1):21-30. PubMed ID: 12361987
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of apoB-100 Peptide-Specific CD8+ T Cells in Atherosclerosis.
    Dimayuga PC; Zhao X; Yano J; Lio WM; Zhou J; Mihailovic PM; Cercek B; Shah PK; Chyu KY
    J Am Heart Assoc; 2017 Jul; 6(7):. PubMed ID: 28711866
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Endothelin-1 overexpression exacerbates atherosclerosis and induces aortic aneurysms in apolipoprotein E knockout mice.
    Li MW; Mian MO; Barhoumi T; Rehman A; Mann K; Paradis P; Schiffrin EL
    Arterioscler Thromb Vasc Biol; 2013 Oct; 33(10):2306-15. PubMed ID: 23887640
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Deletion of angiotensin-converting enzyme 2 promotes the development of atherosclerosis and arterial neointima formation.
    Sahara M; Ikutomi M; Morita T; Minami Y; Nakajima T; Hirata Y; Nagai R; Sata M
    Cardiovasc Res; 2014 Feb; 101(2):236-46. PubMed ID: 24193738
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of Bortezomib on Angiotensin Ⅱ-induced Abdominal Aortic Aneurysm in ApoE
    Li F; Li H; Tian C; Nie H; Zheng Y
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2017 Feb; 39(1):120-127. PubMed ID: 28270294
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Novel vaccines against M. tuberculosis].
    Okada M
    Kekkaku; 2006 Dec; 81(12):745-51. PubMed ID: 17240920
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mesenchymal stem cell-derived conditioned medium attenuate angiotensin II-induced aortic aneurysm growth by modulating macrophage polarization.
    Zhou YZ; Cheng Z; Wu Y; Wu QY; Liao XB; Zhao Y; Li JM; Zhou XM; Fu XM
    J Cell Mol Med; 2019 Dec; 23(12):8233-8245. PubMed ID: 31583844
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cigarette smoke enhances abdominal aortic aneurysm formation in angiotensin II-treated apolipoprotein E-deficient mice.
    Stolle K; Berges A; Lietz M; Lebrun S; Wallerath T
    Toxicol Lett; 2010 Dec; 199(3):403-9. PubMed ID: 20937366
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.